Contribution: Industrial Research Assistance Program – Contributions to Firms
Kapoose Creek Bio Corporation
$500,000.00
unEarthRx'-ADC-Biome: AI-DrivenPre-screening by Biocortex's Mirrorplatform of Novel ADC Payloads forMicrobiome-Mediated Metabolism
EF 2025-26 · 2025-08-01
Résumé
Our Canada-UK project with BioCorteX uses AI to pre-screen novel ADC payloads from our unique fungal library for microbiome interactions. This collaboration aims to de-risk and accelerate the development of safer, more effective cancer therapeutics by understanding how these complex drugs interact with gut and tumour bacteria.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
792582066
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is 500,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 500 000 dollars.
Agreement End Date
2027-02-15
Agreement Number
1035446
Agreement Start Date
2025-08-01
Agreement Title
unEarthRx'-ADC-Biome: AI-DrivenPre-screening by Biocortex's Mirrorplatform of Novel ADC Payloads forMicrobiome-Mediated Metabolism
Agreement Title (French)
unEarthRx'-ADC-Biome : présélection basée sur l’IA par la plateforme Mirror de Biocortex de nouvelles charges utiles ADC pour le métabolisme médié par le microbiome
Agreement Type
Contribution
Agreement Value
$500,000.00
Amendment Date
2025-12-18
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Our Canada-UK project with BioCorteX uses AI to pre-screen novel ADC payloads from our unique fungal library for microbiome interactions. This collaboration aims to de-risk and accelerate the development of safer, more effective cancer therapeutics by understanding how these complex drugs interact with gut and tumour bacteria.
Description (French)
Notre projet canado-britannique avec BioCorteX utilise l’IA pour présélectionner de nouvelles charges utiles ADC à partir de notre bibliothèque unique de champignons pour les interactions microbiologiques. Cette collaboration vise à réduire les risques et à accélérer le développement de traitements anticancéreux plus sûrs et plus efficaces en comprenant comment ces médicaments complexes interagissent avec les bactéries intestinales et tumorales.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
792582066
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Kapoose Creek Bio Corporation
Recipient Postal Code
V6H 3Y4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q3-1035446
